News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Krieg Arthur M
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/21/2021 |
4
| Krieg Arthur M (Chief Scientific Officer) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.
Txns:
| Bought 7,224 shares
@ $6.04, valued at
$43.6k
|
|
06/17/2021 |
4
| Krieg Arthur M (Chief Scientific Officer) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.
Txns:
| Bought 3,578 shares
@ $6.18, valued at
$22.1k
|
|
06/01/2021 |
4
| Krieg Arthur M (Chief Scientific Officer) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.
Txns:
| Disposed of 68,457 shares
@ $0 |
|
05/19/2021 |
4
| Krieg Arthur M (Chief Scientific Officer) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.
Txns:
| Bought 25,001 shares
@ $6.97, valued at
$174.3k
|
|
03/31/2021 |
4
| Krieg Arthur M (Chief Scientific Officer) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.
Txns:
| Bought 17,468 shares
@ $10.94, valued at
$191.1k
Bought 15,752 shares
@ $11.4, valued at
$179.6k
|
|
03/29/2021 |
4
| Krieg Arthur M (Chief Scientific Officer) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.
Txns:
| Bought 10,036 shares
@ $12.35, valued at
$123.9k
Bought 3,484 shares
@ $12.15, valued at
$42.3k
|
|
01/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/23/2020 |
4
| Krieg Arthur M (Chief Scientific Officer) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.
Txns:
| Bought 5,103 shares
@ $14.64, valued at
$74.7k
|
|
12/17/2020 |
4
| Krieg Arthur M (Chief Scientific Officer) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.
Txns:
| Bought 42 shares
@ $14.49, valued at
$608.6 Bought 4,805 shares
@ $14.62, valued at
$70.2k
|
|
08/06/2020 |
3
| Krieg Arthur M (Chief Scientific Officer) has filed a Form 3 on Checkmate Pharmaceuticals, Inc. |
|
|